The effect of radiation on the immune response to cancers

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 927-943

  Park, Bonggoo ^a   Yee, Cassian ^b   Lee, Kyung Mi ^a  

^a Korea University College of Medicine   (South Korea)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Abscopal effect; Cell therapy; Radiation; Recognition; Trafficking

Indexed keywords

ADENOSINE A2A RECEPTOR; BETA INTERFERON; CALRETICULIN; CANCER TESTIS ANTIGEN; CHEMOKINE RECEPTOR CXCR6; CXCL16 CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS ANTIGEN; FLUOROURACIL; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HIGH MOBILITY GROUP B1 PROTEIN; HYDROXYUREA; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOMYCIN; MYELOID DIFFERENTIATION FACTOR 88; NATURAL KILLER CELL RECEPTOR NKG2D; PROGRAMMED DEATH 1 LIGAND 1; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VELIPARIB;

ABSCOPAL EFFECT; ANTINEOPLASTIC ACTIVITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL KILLING; CELL MIGRATION; CELL THERAPY; CLINICAL TRIAL (TOPIC); CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; DRUG MEGADOSE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION RESPONSE; REGULATORY T LYMPHOCYTE; REVIEW; SURVIVAL; UPREGULATION; VACCINATION;

ANIMALS; HUMANS; IMMUNITY; LYMPHOCYTES; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84892412579     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15010927     Document Type: Review

References (73)

1. Aoyama, H.; Shirato, H.; Kakuto, Y.; Inakoshi, H.; Nishio, M.; Yoshida, H.; Hareyama, M.; Yanagisawa, T.; Watarai, J.; Miyasaka, K. Pathologically-proven intracranial germinoma treated with radiation therapy. Radiother. Oncol. 1998, 47, 201-205.
2. Ross, G. M. Induction of cell death by radiotherapy. Endocr.-Relat. Cancer 1999, 6, 41-44.
3. Nam, H. Y.; Han, M. W.; Chang, H. W.; Kim, S. Y.; Kim, S. W. Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence. Autophagy 2013, 9, 1631-1632.
4. Nam, H. Y.; Han, M. W.; Chang, H. W.; Lee, Y. S.; Lee, M.; Lee, H. J.; Lee, B. W.; Lee, K. E.; Jung, M. K.; Jeon, H.; et al. Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res. 2013, 73, 4267-4277.
5. Truman, J. P.; Gueven, N.; Lavin, M.; Leibel, S.; Kolesnick, R.; Fuks, Z.; Haimovitz-Friedman, A. Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J. Biol. Chem. 2005, 280, 23262-23272.
6. Eriksson, D.; Stigbrand, T. Radiation-induced cell death mechanisms. Tumour Biol. 2010, 31, 363-372.
7. Verheij, M.; Bartelink, H. Radiation-induced apoptosis. Cell Tissue Res. 2000, 301, 133-142.
8. Ohba, K.; Omagari, K.; Nakamura, T.; Ikuno, N.; Saeki, S.; Matsuo, I.; Kinoshita, H.; Masuda, J.; Hazama, H.; Sakamoto, I.; et al. Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis. Gut 1998, 43, 575-577.
9. Burnette, B. C.; Liang, H.; Lee, Y.; Chlewicki, L.; Khodarev, N. N.; Weichselbaum, R. R.; Fu, Y. X.; Auh, S. L. The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity. Cancer Res. 2011, 71, 2488-2496.
10. Shiraishi, K.; Ishiwata, Y.; Nakagawa, K.; Yokochi, S.; Taruki, C.; Akuta, T.; Ohtomo, K.; Matsushima, K.; Tamatani, T.; Kanegasaki, S. Enhancement of antitumor radiation efficacy and consistent induction of the abscopal effect in mice by ECI301, an active variant of macrophage inflammatory protein-1alpha. Clin. Cancer Res. 2008, 14, 1159-1166.
11. Demaria, S.; Kawashima, N.; Yang, A. M.; Devitt, M. L.; Babb, J. S.; Allison, J. P.; Formenti, S. C. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin. Cancer Res. 2005, 11, 728-734.
12. Demaria, S.; Pilones, K. A.; Formenti, S. C.; Dustin, M. L. Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment. Oncoimmunology 2013, 2, e23127.
13. Postow, M. A.; Callahan, M. K.; Barker, C. A.; Yamada, Y.; Yuan, J.; Kitano, S.; Mu, Z.; Rasalan, T.; Adamow, M.; Ritter, E.; et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N. Engl. J. Med. 2012, 366, 925-931.
14. Meng, Y.; Efimova, E. V.; Hamzeh, K. W.; Darga, T. E.; Mauceri, H. J.; Fu, Y. X.; Kron, S. J.; Weichselbaum, R. R. Radiation-inducible immunotherapy for cancer: Senescent tumor cells as a cancer vaccine. Mol. Ther. 2012, 20, 1046-1055.
15. Lee, Y.; Auh, S. L.; Wang, Y.; Burnette, B.; Meng, Y.; Beckett, M.; Sharma, R.; Chin, R.; Tu, T.; Weichselbaum, R. R.; et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: Changing strategies for cancer treatment. Blood 2009, 114, 589-595.
16. Liao, Y. P.; Wang, C. C.; Butterfield, L. H.; Economou, J. S.; Ribas, A.; Meng, W. S.; Iwamoto, K. S.; McBride, W. H. Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells. J. Immunol. 2004, 173, 2462-2469.
17. Reits, E. A.; Hodge, J. W.; Herberts, C. A.; Groothuis, T. A.; Chakraborty, M.; Wansley, E. K.; Camphausen, K.; Luiten, R. M.; de Ru, A. H.; Neijssen, J.; et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 2006, 203, 1259-1271.
18. Sharma, A.; Bode, B.; Wenger, R. H.; Lehmann, K.; Sartori, A. A.; Moch, H.; Knuth, A.; Boehmer, L.; Broek, M. γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS One 2011, 6, e28217.
19. Newcomb, E. W.; Demaria, S.; Lukyanov, Y.; Shao, Y.; Schnee, T.; Kawashima, N.; Lan, L.; Dewyngaert, J. K.; Zagzag, D.; McBride, W. H.; et al. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Clin. Cancer Res. 2006, 12, 4730-4737.
20. Chiriva-Internati, M.; Grizzi, F.; Pinkston, J.; Morrow, K. J.; D'Cunha, N.; Frezza, E. E.; Muzzio, P. C.; Kast, W. M.; Cobos, E. Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. In vitro Cell. Dev. Biol. Anim. 2006, 42, 89-95.
21. Apetoh, L.; Ghiringhelli, F.; Tesniere, A.; Obeid, M.; Ortiz, C.; Criollo, A.; Mignot, G.; Maiuri, M. C.; Ullrich, E.; Saulnier, P.; et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13, 1050-1059.
22. Suzuki, Y.; Mimura, K.; Yoshimoto, Y.; Watanabe, M.; Ohkubo, Y.; Izawa, S.; Murata, K.; Fujii, H.; Nakano, T.; Kono, K. Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma. Cancer Res. 2012, 72, 3967-3976.
23. Turk, M. J.; Guevara-Patino, J. A.; Rizzuto, G. A.; Engelhorn, M. E.; Sakaguchi, S.; Houghton, A. N. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 2004, 200, 771-782.
24. Qu, Y.; Jin, S.; Zhang, A.; Zhang, B.; Shi, X.; Wang, J.; Zhao, Y. Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice. Radiat. Res. 2010, 173, 148-157.
25. Kachikwu, E. L.; Iwamoto, K. S.; Liao, Y. P.; DeMarco, J. J.; Agazaryan, N.; Economou, J. S.; McBride, W. H.; Schaue, D. Radiation enhances regulatory T cell representation. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81, 1128-1135.
26. Schaue, D.; Ratikan, J. A.; Iwamoto, K. S.; McBride, W. H. Maximizing tumor immunity with fractionated radiation. Int. J. Radiat. Oncol. Biol. Phys. 2012, 83, 1306-1310.
27. Mandapathil, M.; Szczepanski, M. J.; Szajnik, M.; Ren, J.; Lenzner, D. E.; Jackson, E. K.; Gorelik, E.; Lang, S.; Johnson, J. T.; Whiteside, T. L. Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer. Clin. Cancer Res. 2009, 15, 6348-6357.
28. Chen, W.; Jin, W.; Hardegen, N.; Lei, K. J.; Li, L.; Marinos, N.; McGrady, G.; Wahl, S. M. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 2003, 198, 1875-1886.
29. Antoniades, J.; Brady, L. W.; Lightfoot, D. A. Lymphangiographic demonstration of the abscopal effect in patients with malignant lymphomas. Int. J. Radiat. Oncol. Biol. Phys. 1977, 2, 141-147.
30. Isobe, Y.; Aritaka, N.; Sasaki, M.; Oshimi, K.; Sugimoto, K. Spontaneous regression of natural killer cell lymphoma. J. Clin. Pathol. 2009, 62, 647-650.
31. Lakshmanagowda, P. B.; Viswanath, L.; Thimmaiah, N.; Dasappa, L.; Supe, S. S.; Kallur, P. Abscopal effect in a patient with chronic lymphocytic leukemia during radiation therapy: A case report. Cases J. 2009, 2, 204.
32. Cotter, S. E.; Dunn, G. P.; Collins, K. M.; Sahni, D.; Zukotynski, K. A.; Hansen, J. L.; O'Farrell, D. A.; Ng, A. K.; Devlin, P. M.; Wang, L. C. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: Potential role of induced antitumor immunity. Arch. Dermatol. 2011, 147, 870-872.
33. Takaya, M.; Niibe, Y.; Tsunoda, S.; Jobo, T.; Imai, M.; Kotani, S.; Unno, N.; Hayakawa, K. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uterine cervical carcinoma-A case report. Anticancer Res. 2007, 27, 499-503.
34. Okuma, K.; Yamashita, H.; Niibe, Y.; Hayakawa, K.; Nakagawa, K. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: A case report. J. Med. Case Rep. 2011, 5, 111.
35. Niibe, Y.; Chang, J. Y. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm. Med. 2012, 2012, 261096.
36. Niibe, Y.; Hayakawa, K. Oligometastases and oligo-recurrence: The new era of cancer therapy. Jpn. J. Clin. Oncol. 2010, 40, 107-111.
37. Niibe, Y.; Nishimura, T.; Inoue, T.; Karasawa, K.; Shioyama, Y.; Ogawa, Y.; Takemoto, M.; Shirato, H. Oligometastases of brain only in patients with Non-Small Cell Lung Cancer (NSCLC) treated with Stereotactic Irradiation (STI): A multi-institutional study in Japan. Int. J. Radiat. Oncol. 2010, 78, S497-S497.
38. Corbin, K. S.; Hellman, S.; Weichselbaum, R. R. Extracranial oligometastases: A subset of metastases curable with stereotactic radiotherapy. J. Clin. Oncol. 2013, 31, 1384-1390.
39. Masucci, G. V.; Wersall, P.; Kiessling, R.; Lundqvist, A.; Lewensohn, R. Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours. J. Transl. Med. 2012, 10, 104.
40. Seung, S. K.; Curti, B. D.; Crittenden, M.; Walker, E.; Coffey, T.; Siebert, J. C.; Miller, W.; Payne, R.; Glenn, L.; Bageac, A.; Urba, W. J. Phase 1 study of stereotactic body radiotherapy and interleukin-2-Tumor and immunological responses. Sci. Transl. Med. 2012, 4, doi: 10. 1126/scitranslmed. 3003649.
41. Lugade, A. A.; Moran, J. P.; Gerber, S. A.; Rose, R. C.; Frelinger, J. G.; Lord, E. M. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J. Immunol. 2005, 174, 7516-7523.
42. Cao, Z. A.; Daniel, D.; Hanahan, D. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer 2002, 2, 11.
43. Lugade, A. A.; Sorensen, E. W.; Gerber, S. A.; Moran, J. P.; Frelinger, J. G.; Lord, E. M. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. J. Immunol. 2008, 180, 3132-3139.
44. Hareyama, M.; Imai, K.; Oouchi, A.; Takahashi, H.; Hinoda, Y.; Tsujisaki, M.; Adachi, M.; Shonai, T.; Sakata, K.; Morita, K. The effect of radiation on the expression of intercellular adhesion molecule-1 of human adenocarcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 1998, 40, 691-696.
45. Matsumura, S.; Wang, B.; Kawashima, N.; Braunstein, S.; Badura, M.; Cameron, T. O.; Babb, J. S.; Schneider, R. J.; Formenti, S. C.; Dustin, M. L.; et al. Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. J. Immunol. 2008, 181, 3099-3107.
46. Draghiciu, O.; Walczak, M.; Hoogeboom, B. N.; Franken, K. L.; Melief, K. J.; Nijman, H. W.; Daemen, T. Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination. Int. J. Cancer 2013, 134, 859-872.
47. Gasser, S.; Orsulic, S.; Brown, E. J.; Raulet, D. H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005, 436, 1186-1190.
48. Chakraborty, M.; Abrams, S. I.; Camphausen, K.; Liu, K.; Scott, T.; Coleman, C. N.; Hodge, J. W. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J. Immunol. 2003, 170, 6338-6347.
49. Garnett, C. T.; Palena, C.; Chakraborty, M.; Tsang, K. Y.; Schlom, J.; Hodge, J. W. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res. 2004, 64, 7985-7994.
50. Chakraborty, M.; Abrams, S. I.; Coleman, C. N.; Camphausen, K.; Schlom, J.; Hodge, J. W. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res. 2004, 64, 4328-4337.
51. Liang, H.; Deng, L.; Chmura, S.; Burnette, B.; Liadis, N.; Darga, T.; Beckett, M. A.; Lingen, M. W.; Witt, M.; Weichselbaum, R. R.; et al. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. J. Immunol. 2013, 190, 5874-5881.
52. Caligiuri, M. A. Human natural killer cells. Blood 2008, 112, 461-469.
53. Ljunggren, H. G.; Malmberg, K. J. Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 2007, 7, 329-339.
54. Watzl, C.; Long, E. O. Exposing tumor cells to killer cell attack. Nat. Med. 2000, 6, 867-868.
55. Pardoll, D. M. Immunology. Stress, NK receptors, and immune surveillance. Science 2001, 294, 534-536.
56. Zarybnicka, L.; Vavrova, J.; Havelek, R.; Tichy, A.; Pejchal, J.; Sinkorova, Z. Lymphocyte subsets and their H2AX phosphorylation in response to in vivo irradiation in rats. Int. J. Radiat. Biol. 2013, 89, 110-117.
57. Zarcone, D.; Tilden, A. B.; Lane, V. G.; Grossi, C. E. Radiation sensitivity of resting and activated nonspecific cytotoxic cells of T lineage and NK lineage. Blood 1989, 73, 1615-1621.
58. Mizutani, Y.; Uchida, A.; Fujimoto, T.; Ikenaga, M.; Yoshida, O. Enhancement by X-ray irradiation of target cell susceptibility to natural killer cells. Immunol. Lett 1989, 22, 247-251.
59. Uchida, A.; Mizutani, Y.; Nagamuta, M.; Ikenaga, M. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells. Immunopharmacol. Immunotoxicol. 1989, 11, 507-519.
60. Halpern, J. N.; Cohen, E.; Mekori, T.; Beny, A. N.; Kuten, A.; Rosenblatt, E. A.; Robinson, E. The effect of in vitro irradiation on human NK cell activity. A preliminary report. J. Med. 1991, 22, 243-254.
61. Shin, S. C.; Lee, K. M.; Kang, Y. M.; Kim, K.; Kim, C. S.; Yang, K. H.; Jin, Y. W.; Kim, H. S. Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation. Biochem. Biophys. Res. Commun. 2010, 397, 644-649.
62. Sonn, C. H.; Choi, J. R.; Kim, T. J.; Yu, Y. B.; Kim, K.; Shin, S. C.; Park, G. H.; Shirakawa, T.; Kim, H. S.; Lee, K. M. Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2. J. Radiat. Res. 2012, 53, 823-829.
63. Nakagawa, K.; Yoshida, F.; Omori, N.; Tsunoda, T.; Nose, T. The effect of radiation therapy combined with natural killer cells against spontaneous murine fibrosarcoma. Biotherapy 1990, 2, 69-75.
64. Nowosielska, E. M.; Cheda, A.; Wrembel-Wargocka, J.; Janiak, M. K. Effect of low doses of low-let radiation on the innate anti-tumor reactions in radioresistant and radiosensitive mice. Dose Response 2012, 10, 500-515.
65. Yang, K. L.; Wang, Y. S.; Chang, C. C.; Huang, S. C.; Huang, Y. C.; Chi, M. S.; Chi, K. H. Reciprocal complementation of the tumoricidal effects of radiation and natural killer cells. PLoS One 2013, 8, e61797.
66. Begovic, M.; Herberman, R.; Gorelik, E. Increase in immunogenicity and sensitivity to natural cell-mediated cytotoxicity following in vitro exposure of MCA105 tumor cells to ultraviolet radiation. Cancer Res. 1991, 51, 5153-5159.
67. Begovic, M.; Herberman, R. B.; Gorelik, E. Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity. Cell. Immunol. 1991, 138, 349-359.
68. Begovic, M.; Herberman, R. B.; Gorelik, E. Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis. Nat. Immun. 1993, 12, 250-266.
69. Liu, L. L.; Smith, M. J.; Sun, B. S.; Wang, G. J.; Redmond, H. P.; Wang, J. H. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Ann. Surg. Oncol. 2009, 16, 1403-1411.
70. Ni, J.; Miller, M.; Stojanovic, A.; Garbi, N.; Cerwenka, A. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 2012, 209, 2351-2365.
71. Lim, S. A.; Kim, T. J.; Lee, J. E.; Sonn, C. H.; Kim, K.; Kim, J.; Choi, J. G.; Choi, I. K.; Yun, C. O.; Kim, J. H.; et al. Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy. Cancer Res. 2013, 73, 2598-2607.
72. Fujisaki, H.; Kakuda, H.; Shimasaki, N.; Imai, C.; Ma, J.; Lockey, T.; Eldridge, P.; Leung, W. H.; Campana, D. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res. 2009, 69, 4010-4017.
73. Denman, C. J.; Senyukov, V. V.; Somanchi, S. S.; Phatarpekar, P. V.; Kopp, L. M.; Johnson, J. L.; Singh, H.; Hurton, L.; Maiti, S. N.; Huls, M. H.; et al. Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells. PLoS One 2012, 7, e30264.